Vitamin D and aging: old concepts and new insights.

Aging is a complex biological process driven by a selective class of molecules and pathways that affect overall deterioration of physiological functions to increase the risk of age-related diseases. A role of vitamin D in mammalian aging is well documented. Since vitamin D has an essential role in bone formation and mineralization, its deficiency results in impaired bone mineralization, such as rickets in children, osteomalacia in adults and osteoporosis in the aged population. Vitamin D replacement therapy therefore is one of the most commonly prescribed treatments for the elderly. Recent studies using genetically altered mouse models, such as in Fgf-23(-/-) and klotho mutant mice, that exhibit altered mineral ion metabolism due to high vitamin D activities showed features of premature aging that include atherosclerosis, emphysema, osteopenia/osteoporosis, hypogonadism, soft tissue calcifications and generalized atrophy of organs; the pathologic effects of vitamin D in these mouse models are obvious, as diminution or genetic ablation of the vitamin D pathway ameliorated most of the above-mentioned phenotypes, by reversing mineral ion metabolism, and the resultant effect being prolonged survival of the mutant mice. These in vivo mouse studies, although subject to further molecular characterization, add new insights into the role of vitamin D in aging.

[1]  B. Diffey,et al.  Subliminal ultraviolet‐B irradiation for the prevention of vitamin D deficiency in the elderly: a feasibility study , 2001, Photodermatology, photoimmunology & photomedicine.

[2]  H. DeLuca,et al.  Regulation of 25-hydroxyvitamin D3 1alpha-hydroxylase gene expression by parathyroid hormone and 1,25-dihydroxyvitamin D3. , 2000, Archives of biochemistry and biophysics.

[3]  R. Baron,et al.  Targeted ablation of the vitamin D receptor: an animal model of vitamin D-dependent rickets type II with alopecia. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[4]  R. Baron,et al.  Rescue of the Skeletal Phenotype of Vitamin D Receptor-Ablated Mice in the Setting of Normal Mineral Ion Homeostasis: Formal Histomorphometric and Biomechanical Analyses1. , 1999, Endocrinology.

[5]  C. Hoppel,et al.  Oxidative phosphorylation and aging , 2006, Ageing Research Reviews.

[6]  T. Meitinger,et al.  Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23 , 2000, Nature Genetics.

[7]  F. Oppenheimer,et al.  Uremic tumoral calcinosis in patients receiving longterm hemodialysis therapy. , 1999, The Journal of rheumatology.

[8]  M. Holick,et al.  AGE, VITAMIN D, AND SOLAR ULTRAVIOLET , 1989, The Lancet.

[9]  M. Razzaque,et al.  Homozygous ablation of fibroblast growth factor-23 results in hyperphosphatemia and impaired skeletogenesis, and reverses hypophosphatemia in Phex-deficient mice. , 2004, Matrix biology : journal of the International Society for Matrix Biology.

[10]  L. Mosekilde Vitamin D and the elderly , 2005, Clinical endocrinology.

[11]  G. Åkerström,et al.  25-hydroxyvitamin D(3)-1alpha-hydroxylase expression in normal and pathological parathyroid glands. , 2002, The Journal of clinical endocrinology and metabolism.

[12]  Tadashi Kaname,et al.  Mutation of the mouse klotho gene leads to a syndrome resembling ageing , 1997, Nature.

[13]  S. Reid,et al.  On the ontogeny and interactions of phosphofructokinase in mouse tissues. , 1986, The International journal of biochemistry.

[14]  P. Orlik,et al.  An FGF23 missense mutation causes familial tumoral calcinosis with hyperphosphatemia. , 2005, Human molecular genetics.

[15]  M. Razzaque,et al.  Hypervitaminosis D and premature aging: lessons learned from Fgf23 and Klotho mutant mice. , 2006, Trends in molecular medicine.

[16]  M. Razzaque,et al.  Premature aging in klotho mutant mice: Cause or consequence? , 2007, Ageing Research Reviews.

[17]  L. Bouter,et al.  Vitamin D Supplementation and Fracture Incidence in Elderly Persons , 1996, Annals of Internal Medicine.

[18]  D. Arking,et al.  Association Between a Functional Variant of the KLOTHO Gene and High-Density Lipoprotein Cholesterol, Blood Pressure, Stroke, and Longevity , 2005, Circulation research.

[19]  I. Holm,et al.  Hypervitaminosis D associated with drinking milk. , 1992, The New England journal of medicine.

[20]  Tatsuya Yoshizawa,et al.  Mice lacking the vitamin D receptor exhibit impaired bone formation, uterine hypoplasia and growth retardation after weaning , 1997, Nature Genetics.

[21]  M. Razzaque,et al.  Life-long suppression of growth hormone-insulin-like growth factor I activity in genetically altered rats could prevent age-related renal damage. , 2006, Endocrinology.

[22]  M. Razzaque,et al.  FGF-23, vitamin D and calcification: the unholy triad. , 2005, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[23]  H. Pols,et al.  Vitamin D , 1928, Calcified Tissue International.

[24]  R. Baron,et al.  Printed in U.S.A. Copyright © 1999 by The Endocrine Society Rescue of the Skeletal Phenotype of Vitamin D Receptor- Ablated Mice in the Setting of Normal Mineral Ion , 2022 .

[25]  Torben A. Kruse,et al.  Design and analysis in genetic studies of human ageing and longevity , 2006, Ageing Research Reviews.

[26]  M. Kuro-o,et al.  Disease model: human aging. , 2001, Trends in molecular medicine.

[27]  J. Manson,et al.  Calcium plus vitamin D supplementation and the risk of fractures. , 2006, The New England journal of medicine.

[28]  M. Kuro-o Klotho as a regulator of fibroblast growth factor signaling and phosphate/calcium metabolism , 2006, Current opinion in nephrology and hypertension.

[29]  E. Harju,et al.  Annual injection of vitamin D and fractures of aged bones , 1992, Calcified Tissue International.

[30]  M. Razzaque,et al.  Premature aging‐like phenotype in fibroblast growth factor 23 null mice is a vitamin D‐mediated process , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[31]  M. Razzaque,et al.  Genetic ablation of vitamin D activation pathway reverses biochemical and skeletal anomalies in Fgf-23-null animals. , 2006, The American journal of pathology.

[32]  T. Chen,et al.  Vitamin D intoxication associated with an over-the-counter supplement. , 2001, The New England journal of medicine.

[33]  Andrew Scutt,et al.  Aging of mesenchymal stem cells , 2006, Ageing Research Reviews.

[34]  K. Fukuda,et al.  Klotho, a gene related to a syndrome resembling human premature aging, functions in a negative regulatory circuit of vitamin D endocrine system. , 2003, Molecular endocrinology.

[35]  Y. Nabeshima Klotho: a fundamental regulator of aging , 2002, Ageing Research Reviews.

[36]  Y. Takeuchi,et al.  Targeted ablation of Fgf23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism. , 2004, The Journal of clinical investigation.

[37]  John Adams,et al.  Gains in Bone Mineral Density with Resolution of Vitamin D Intoxication , 1997, Annals of Internal Medicine.

[38]  Olivier Dardenne,et al.  Targeted Inactivation of the 25-Hydroxyvitamin D3-1α-Hydroxylase Gene (CYP27B1) Creates an Animal Model of Pseudovitamin D-Deficiency Rickets. , 2001, Endocrinology.

[39]  G. Åkerström,et al.  25-hydroxyvitamin D3-1α-hydroxylase expression in normal and pathological parathyroid glands , 2002 .

[40]  R. Doll,et al.  Effect of four monthly oral vitamin D3 (cholecalciferol) supplementation on fractures and mortality in men and women living in the community: randomised double blind controlled trial , 2003, BMJ : British Medical Journal.

[41]  S. Ginsberg,et al.  Expression profiling in the aging brain: A perspective , 2005, Ageing Research Reviews.

[42]  M. Pahor,et al.  Mitochondrial DNA mutations, energy metabolism and apoptosis in aging muscle , 2006, Ageing Research Reviews.

[43]  G. Eknoyan,et al.  Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. , 2003, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[44]  H. Faure,et al.  Physical activity alters antioxidant status in exercising elderly subjects. , 2006, The Journal of nutritional biochemistry.

[45]  P. Lips,et al.  Vitamin D deficiency and secondary hyperparathyroidism in the elderly: consequences for bone loss and fractures and therapeutic implications. , 2001, Endocrine reviews.

[46]  P. Ureña,et al.  Recent findings in phosphate homeostasis , 2005, Current opinion in nephrology and hypertension.

[47]  N. Amizuka,et al.  Targeted inactivation of Npt2 in mice leads to severe renal phosphate wasting, hypercalciuria, and skeletal abnormalities. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[48]  G E Dallal,et al.  Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age or older. , 1997, The New England journal of medicine.

[49]  J. Goff,et al.  Calcium and Vitamin D Metabolism During Lactation , 1997, Journal of Mammary Gland Biology and Neoplasia.

[50]  Dongxu Sun,et al.  Effect of fish oil on bone mineral density in aging C57BL/6 female mice. , 2007, The Journal of nutritional biochemistry.

[51]  F. Glorieux,et al.  Targeted inactivation of the 25-hydroxyvitamin D(3)-1(alpha)-hydroxylase gene (CYP27B1) creates an animal model of pseudovitamin D-deficiency rickets. , 2001, Endocrinology.

[52]  F. Glorieux,et al.  Correction of the abnormal mineral ion homeostasis with a high-calcium, high-phosphorus, high-lactose diet rescues the PDDR phenotype of mice deficient for the 25-hydroxyvitamin D-1alpha-hydroxylase (CYP27B1). , 2003, Bone.

[53]  Y. Frishberg,et al.  Hyperostosis–Hyperphosphatemia Syndrome: A Congenital Disorder of O‐Glycosylation Associated With Augmented Processing of Fibroblast Growth Factor 23 , 2006, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[54]  H. DeLuca,et al.  Expression of 1,25-dihydroxyvitamin D(3) receptor in the immune system. , 2000, Archives of biochemistry and biophysics.

[55]  A. Zinsmeister,et al.  Soft tissue calcification in pediatric patients with end-stage renal disease , 1991, Pediatric Nephrology.

[56]  N. Seyahi,et al.  Intracranial calcification and tumoural calcinosis during vitamin D therapy , 2004, Nephrology.

[57]  M. Fukagawa,et al.  Role of fibroblast growth factor 23 in health and in chronic kidney disease , 2005, Current opinion in nephrology and hypertension.